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tracking) may mitigate the detrimental effects of motion, but 
requires reliable target motion monitoring. On a conventional 
linac, monitoring can be obtained by intrafraction kilovoltage 
monitoring (KIM) using continuous imaging of implanted 
fiducials with a standard gantry-mounted x-ray imager. 
However, KIM adds imaging dose, is incompatible with large 
couch rotation, and KIM images suffer from MV scatter onto 
the kV imager. This study investigates the use of external 
monitoring combined with sparse kV imaging during beam 
pauses to overcome KIM limitations. 
 
Material and Methods: Six patients with 2-3 implanted gold 
markers received three fraction liver SBRT on a conventional 
linac. A setup CBCT was acquired with simultaneous 
recording of the motion of an external marker block on the 
abdomen (Fig. A). The 3D marker motion during the CBCT 
was estimated at 15Hz from the 2D motion in the CBCT 
projections and used to establish an external correlation 
model (ECM) of the internal marker motion INT(t) in each 
direction (RL, SI, AP) as a function of the external marker 
block motion EXT(t): INT(t) = A·EXT(t) + B·EXT(t-τ) +C, where 
A, B, C are coefficients and τ is a time constant. During 
treatment delivery, INT(t) was estimated from the external 
motion at 20Hz, while MV-scatter-free kV images were 
acquired every 3s during beam pauses. INT(t) was estimated 
from the ECM of the CBCT without any model update and 
with updates of the coefficient CSI by use of the first image 
of each treatment field. Post-treatment, the 3D marker 
positions were estimated for each intra-treatment kV image 
and used as ground truth to quantify the root mean square 
error (rmse) of the INT(t) estimations.  
 
Results: Figs. B-C compare the estimated INT(t) with and 
without model updates with the ground truth positions in 
intra-treatment kV images at one fraction. Table 1 shows the 
mean rmse for all fractions. ECM updates more than halved 
the SI rmse. Substantial internal cranial baseline drift up to 7 
mm (mean 1.4 mm) occurred between the setup CBCT and 
the last field without a similar drift for the external 
surrogate, illustrating the need for intra-treatment ECM 
updates.  
 
 
 
 
Conclusion: A correlation model between external surrogate 
motion and internal liver motion was established on a 
conventional linac from pre-treatment CBCT projections and 
used to estimate the intra-treatment target positions with 
and without model update. A simple update based on only 
one kV image per field substantially improved the 
localization accuracy. Real-time update of the model in all 3 
motion directions is currently being developed and is 
expected to further improve the localization accuracy. The 
proposed method increases the versatility and reduces the 
imaging dose compared to current clinical KIM 
implementations. 
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Purpose or Objective: Rotational radiotherapy IMRT (VMAT) 
has shown superior delivery efficiency with similar overall 
treatment plan quality compared to conventional IMRT. For 
lung treatments intra-fractional tumor motion is a major 
source of uncertainty in dose application leading to the 
enlargement of the PTV margins and possibly to increased 
dose delivery to OARs. Motion management by tracking the 
tumor using intra-fractional kV planar images has the 
potential to reduce position uncertainty and reduce the PTV 
margins. The challenge for rotational treatments is the poor 
tumor visibility at certain gantry angles. In this work we 
investigate the feasibility of delivering VMAT treatments 
using only partial arcs where the tumor is well visible and 
therefore tracking is feasible. 
 
Material and Methods: For our study we used the x-ray 
images acquired for CBCT reconstruction from five patients 
with NSCLC undergoing hypo-fractionated SBRT treatment (3 
fractions of 13.5Gy prescribed to the 65% isodose). These x-
rays are comparable to kV fluoroscopy images acquired 
during a VMAT treatment. For each patient the evaluation 
consisted of two steps: first real-time 2D/3D registration was 
used to track the tumor location on each of the x-rays from 
the CBCT acquisition. We determined the gantry angle 
intervals for which it was possible to track the tumor by 
comparing registration results with manually annotated 
diaphragm motion. Second, VMAT plans were created for 
partial arcs chosen depending on the anatomy and tumor 
location (U=unlimited) for a PTV based on an ITV approach 
(ITV plus 4mm margin) and for the limited partial arcs where 
the tumor tracking worked (L=limited) for a PTV based on the 
midventilation CTV (5mm margin). The L partial arc plans 
were evaluated using the U plans as benchmark. 
 
Results: For all cases is was possible to track the tumor in 
two arcs of about 90 degrees, typically with imaging around 
anterior-posterior (AP) or posterior-anterior (PA) projections. 
For patient 5 it was possible to track the tumor in all 
projections. In terms of plan quality, a target coverage of at 
least 99% to the 65% isodose was aimed for and could be 
achieved for all the U plans and for all the L plans except for 
one, where the available angle range led to an unfavorable 
dose distribution, which would be clinically not acceptable. 
Therefore this patient was omitted for further data 
evaluation. Table 1 summarizes the tracking angles and the 
DVH parameters. Figure 1 shows example tracking results and 
obtained plans for one patient. 
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Conclusion: The results indicate the feasibility of VMAT 
treatments under tumor tracking for selected patients. The 
arcs available for planning influence the quality of 
treatment. The L partial arc plans had clinically acceptable 
quality in four patients. Treatments with reduced margins 
could be safely delivered by gating the treatment beam if the 
tumor motion exceeds the margins. Also, a great advantage is 
that the dose delivered to the tumor could be exactly 
monitored. 
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Purpose or Objective: Pancreatic cancer with vascular 
involvement has a poor prognosis regardless of treatment. 
The toxicity of chemoradiation to adjacent normal organs can 
contribute to treatment discontinuation and adverse 
outcomes in some patients. We hypothesized that real-time 
MRI guided radiotherapy for borderline or locally advanced 
pancreatic carcinoma would enable safer treatment delivery 
with tight margins and diminished normal tissue toxicity than 
conventional treatment approaches. 
 
Material and Methods: Patients with borderline or locally 
advanced pancreatic cancer were eligible for evaluation for 
MRI-guided radiotherapy. Patients underwent complete 
staging, including baseline CA19-9 and triple phase CT 
imaging. Patients underwent simulation with an inhale breath 
hold 3D and cine scans on a MRI Guided Treatment Planning 
system. Locoregional lymph node coverage was incorporated 
at the discretion of the Radiation Oncologist. The mean CTV 
to PTV expansion was 3 mm (range 2-5 mm). The primary 
GTV was tracked in real-time throughout treatment and the 
PTV or similar structure was used as a boundary for triggering 
treatment. A patient initiated repeated breath hold strategy 
was used to increase the reproducibility and duty cycle of 
radiotherapy. 
 
Results: We have completed treatment for our first 5 
patients with borderline or locally advanced pancreatic 
adenocarcinoma. The population was 4:1 Male:Female with a 
mean age of 61.8 years (range 52-67). All patients had an 
elevated CA19-9 at presentation, with a mean of 714 U/mL 
(range 62 – 2350 U/mL). Locoregional lymphatics were 
treated in 4/5 patients. The mean PTV was 222.7 cc (range 
40.3-346.4 cc). The PTV was treated to 50.4 Gy at 1.8 Gy per 
a fraction with concurrent chemotherapy for all patients. 
With a median follow-up of 166 days (range 50 – 278 days), an 
average 66% reduction in CA19-9 1-2 months following 
chemoradiation was observed. The OS is 60% at time of 
follow up. One grade 4 toxicity was observed with duodenal 
ulceration during radiotherapy requiring hospitalization. The 
number of patients, overall survival, local control, 
progression free survival, and changes in CA19-9 levels will be 
updated at the time of presentation. 
 
Conclusion: Real-time MRI-guided radiotherapy enables the 
design and delivery of highly conformal treatment for 
patients with borderline or locally advanced pancreatic 
carcinoma. A significant reduction in CA19-9 levels after 
treatment was observed. Real time MR imaging throughout 
treatment enables high precision tracking to minimize 
treatment margins and normal tissue dose exposure. MRI-
guided radiotherapy may provide opportunities for normal 
organ toxicity reduction and future dose escalation 
strategies. 
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Purpose or Objective: Thedevelopment of radiotherapy 
treatment units with integrated MRI scanners isstimulating 
interest in fully MRI-guided treatment protocols. Cine-
MRIsequences capable of acquiring 5-6 2D images per second 
are already available,thus providing a potential means of 
non-invasive, online motion monitoring withhigh soft-tissue 
contrast. This work investigates the feasibility of livermotion 
tracking using optical flow registration of Cine-MR images 
series. 
 
Material and Methods: Livercine-MRI series (balanced steady-
state free precession, 256x256 pixel, 1.28x1.28mm spacing, f 
= 3.3Hz) providing 220 images over a 70s scan were acquired 
in 25patients and 5 healthy volunteers after informed 
consent. Ground-truth livermotion consisted in the 
trajectories of numerous sparse features (PSIFT) extracted 
using apreviously tested algorithm based on the Scale 
Invariant Feature Transform(SIFT) [1]. For each subject, 
optical flow (OF) registration, as proposed in [2],was applied 
between the first image of the series and each subsequent 
frame,thus obtaining time-resolved dense motion fields [Fig. 
1]. Trajectories basedon OF (POF) were then derivedby 
applying these motion fields to the positions of the SIFT 
features detectedin the first image. To assess the accuracy of 
the motion fields, the 2D frame-by-framedistances (DSIFT-
OF)between PSIFT and POF were calculated forevery trajectory 
and, for each subject, their distributions were described 
withmedian, inter-quartile range, 5th and 95th 
percentiles.Linear correlation coefficients (rSIFT-OF) between 
